BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11359411)

  • 1. Unregulated use of clobetasol propionate.
    Keane FM; Munn SE; Taylor NF; du Vivier AW
    Br J Dermatol; 2001 May; 144(5):1095-6. PubMed ID: 11359411
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
    Tobin AM; Barragry J; Kirby B; O'Shea L
    Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560
    [No Abstract]   [Full Text] [Related]  

  • 4. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
    Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical corticosteroids and bullous pemphigoid.
    Hull CM; McKenna JK; Zone JJ
    Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact allergy to clobetasol propionate.
    Cox NH
    Arch Dermatol; 1988 Jun; 124(6):911-3. PubMed ID: 2967675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-the-counter clobetasol propionate.
    Otley CC; Sober A
    Arch Dermatol; 1994 Jan; 130(1):121. PubMed ID: 8285734
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 10. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib-induced fixed drug eruption.
    Bandyopadhyay D
    Clin Exp Dermatol; 2003 Jul; 28(4):452. PubMed ID: 12823316
    [No Abstract]   [Full Text] [Related]  

  • 12. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediacy is both a liability and an asset of the Internet.
    Huntley A
    Dermatol Online J; 1997 Dec; 3(2):11b. PubMed ID: 10217739
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic contact dermatitis to topical corticosteroids: clobetasol propionate and clobetasone butyrate.
    Dooms-Goossens A; Vanhee J; Vanderheyden D; Gevers D; Willems L; Degreef H
    Contact Dermatitis; 1983 Nov; 9(6):470-8. PubMed ID: 6653104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroids.
    Med Lett Drugs Ther; 1991 Nov; 33(857):108-10. PubMed ID: 1943979
    [No Abstract]   [Full Text] [Related]  

  • 18. Irrational use of skin-bleaching products can delay the diagnosis of leprosy.
    Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM
    Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous hypersensitivity to clobetasone butyrate and clobetasol propionate.
    Chalmers RJ; Beck MH; Muston HL
    Contact Dermatitis; 1983 Jul; 9(4):317-8. PubMed ID: 6225613
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of periocular capillary hemangioma with topical clobetasol propionate.
    Cruz OA; Zarnegar SR; Myers SE
    Ophthalmology; 1995 Dec; 102(12):2012-5. PubMed ID: 9098309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.